CovarsaDx
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8607 Imperial Hwy Ste 103, Downey, Calif...Phone Number
(866) 268-2772Website
www.covarsadx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About CovarsaDx
At CovarsaDx, the company knows that a superior study for rapid market pathways demands agile responses to patient population needs and fluctuations in regulatory requirements.Because of the company's extensive industry experience, the company really understand that every product has unique needs and requirements, and the company collaborates closely with study sponsors and clinicians to customize studies and ensure that your project is informed by disease pathophysiology, prevalence, patient population, clinical impact, and current tests and treatment.Explore more
CovarsaDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CovarsaDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CovarsaDx
Product Launch: Get notified when CovarsaDx launches new products
Funding: Get notified immidiatlly once CovarsaDx has new funding data
Click to see if CovarsaDx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if CovarsaDx has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CovarsaDx recently announced quarterly report
CovarsaDx, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CovarsaDx is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined CovarsaDx as Masked Content
Find 3 more new buyers
Compare Similar Companies to CovarsaDx
Compare insights from companies similar to CovarsaDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CovarsaDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CovarsaDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CovarsaDx.
CovarsaDx Tech Stack
A closer look at the technologies used by CovarsaDx
See more technologies
CovarsaDx News & Media
CovarsaDx Appoints Dr. Karen Shannon as In-House Counsel to Support Continued Growth, Compliance and Innovation
LAS VEGAS, Nov. 19, 2025 /PRNewswire/ -- CovarsaDx®, a leading contract research organization (CRO) specializing in the areas of in vitro diagnostics (IVD) and medical device clinical research, today announced the appointment of Karen L. Shannon, Ph.D., J.D., as in-house counsel. Shannon...CovarsaDx Strengthens Regulatory Expertise with Industry Veteran David Ikeda
LOS ANGELES, Feb. 10, 2025 /PRNewswire/ -- CovarsaDx, a prominent Clinical Research Organization (CRO) well-known for its expertise in the areas of in vitro diagnostics (IVDs) and medical devices, proudly announces the addition of David Ikeda as senior regulatory affairs strategist. Ikeda...CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare's Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test
LOS ANGELES, Jan. 21, 2025 /PRNewswire/ -- CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its expertise in the areas of in-vitro diagnostics (IVDs) and medical devices, proudly announced today that the U.S. Food and Drug Administration (FDA) granted 510(k)...Nuclein's DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
LOS ANGELES, Jan. 7, 2025 /PRNewswire/ -- CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, Nuclein, LLC, has received U.S. Food and Drug...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CovarsaDx
Sign Up For FreeTo access detailed company insights
At CovarsaDx, the company knows that a superior study for rapid market pathways demands agile responses to patient population needs and fluctuations in regulatory requirements.Because of the company's extensive industry experience, the company really understand that every product has unique needs and requirements, and the company collaborates close... Read More
